SEC 1746 Potential persons who are to respond to the collection of
(11-02) information contained in this form are not required to respond
unless the form displays a currently valid OMB control number.
-----------------------------
OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response . . . 11
-----------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13D/A
(Rule 13d-101)
(Amendment No. 18)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULE 13(d)-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13(d)-2(a)
KOOR INDUSTRIES LTD.
(Name of Issuer)
Ordinary Shares/American Depositary Shares
(Title of Class of Securities)
500 507 108
(CUSIP Number)
Marc A. Berger, Esq.
Davies Ward Phillips & Vineberg LLP
625 Madison Ave, 12th Floor, New York, NY 10022
(212) 308-8866
(Name, Address and Telephone Number
of Person Authorized to Receive Notices and Communications)
July 25, 2005
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the
following box. |_|
CUSIP No.: 500 507 108 Schedule 13D Page 2 of 16 Pages
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934, as amended, and the regulations of the Securities and Exchange Commission
promulgated thereunder (the "Exchange Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
CUSIP No.: 500 507 108 Schedule 13D Page 3 of 16 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Claridge Israel LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 2,375,835
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,375,835
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,375,835
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.7%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No.: 500 507 108 Schedule 13D Page 4 of 16 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
CBT Holdings LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 57,576
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
57,576
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
57,576
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|X|**
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.4%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
** Excludes 113,236 Ordinary Shares directly owned by the Charles Rosner
Bronfman Family Trust ("CRBFT"), 2,271,167 Ordinary Shares indirectly
owned by CRBFT, and 611,694 Ordinary Shares directly owned by Anfield Ltd.
that may be deemed to be beneficially owned by CBT Holdings LLC. Please
refer to Section 5(a) of this Amendment No. 18.
CUSIP No.: 500 507 108 Schedule 13D Page 5 of 16 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Charles Rosner Bronfman Family Trust
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
113,236
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 2,271,167
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 113,236
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,271,167
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,384,403
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|X|**
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.8%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
** Excludes 57,576 Ordinary Shares directly owned by CBT Holdings LLC and
611,694 Ordinary Shares directly owned by Anfield Ltd. that may be deemed
to be beneficially owned by the Charles Rosner Bronfman Family Trust.
Please refer to Section 5(a) of this Amendment No. 18.
CUSIP No.: 500 507 108 Schedule 13D Page 6 of 16 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
The Charles Bronfman Trust
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 2,433,411
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,433,411
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,433,411
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|X|**
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
15.1%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
** Excludes 113,236 Ordinary Shares directly owned by the Charles Rosner
Bronfman Family Trust ("CRBFT"), 2,271,167 Ordinary Shares indirectly
owned by CRBFT, and 611,694 Ordinary Shares directly owned by Anfield Ltd.
that may be deemed to be beneficially owned by The Charles Bronfman Trust
as a result of its ownership of CBT Holdings LLC. Please refer to Section
5(a) of this Amendment No. 18.
CUSIP No.: 500 507 108 Schedule 13D Page 7 of 16 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Esarbee Investments Limited
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 2,271,167
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,271,167
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,271,167
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.1%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No.: 500 507 108 Schedule 13D Page 8 of 16 Pages
The following constitutes Amendment No. 18 ("Amendment No. 18") to the Schedule
13D dated October 22, 1997, as amended by Amendment Nos. 1 - 17 (collectively,
the "Original Schedule 13D"). This Amendment No. 18 amends the Original Schedule
13D as specifically set forth herein.
This Amendment No. 18 is being filed by Esarbee Investments Limited, a Canadian
corporation ("Esarbee"), Claridge Israel LLC, a Delaware limited liability
company ("Claridge"), and The Charles Bronfman Trust, a Delaware trust ("CBT"),
all of which are currently Reporting Persons. This Amendment No. 18 is also
being filed on behalf of the following additional Reporting Persons: CBT
Holdings LLC, a Delaware limited liability company wholly owned by CBT ("CBT
Holdings"), and the Charles Rosner Bronfman Family Trust, a trust organized
under the laws of the Province of Quebec and the indirect owner of Esarbee
("CRBFT").
Item 2. Identity and Background.
Item 2 of the Original Schedule 13D is amended by adding the following
thereto:
(a) CBT Holdings and CRBFT.
References herein to the "Schedule I Persons" means the Schedule I Persons
as defined in the Original Schedule 13D, as amended as set forth on Schedule I
hereto.
(b) CRBFT's principal address is located at c/o Claridge, Inc., 1170 Peel
Street, 8th Floor, Montreal, Quebec H3B 4P2 Canada. CBT Holdings' principal
address is located at c/o Withers Bergman LLP, 157 Church Street, New Haven, CT
06510.
(c) The principal business of each of CBT Holdings and CRBFT consists of
the acquisition, ownership, disposition and reinvestment of investment assets
and related business activities.
(d) During the past five years, neither CBT Holdings nor CRBFT, nor (to
their knowledge) any of their respective Schedule I Persons, has been convicted
in a criminal proceeding (excluding traffic violations or similar misdemeanors.)
(e) During the past five years, neither CBT Holdings nor CRBFT, nor (to
their knowledge) any of their respective Schedule I Persons, has been a party to
any civil proceeding of a judicial or administrative body of competent
jurisdiction as a result of which it was or is subject to a judgment, decree or
final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws, or finding any
violation with respect to such laws.
(f) CBT Holdings is a citizen of the United States. CRBFT is a citizen of
Canada.
CUSIP No.: 500 507 108 Schedule 13D Page 9 of 16 Pages
Item 3. Source and Amount of Funds or Other Consideration.
The Original Schedule 13D is amended by inserting the following at the end
of Item 3:
CRBFT and CBT Holdings paid for their Ordinary Shares from working
capital.
Item 4. Purpose of Transaction.
Item 4 in the Original Schedule 13D is hereby deleted and replaced with
the following:
The Ordinary Shares set forth in Section (c) of Item 5 were acquired for
general investment purposes. CBT Holdings, CRBFT and Anfield Ltd., an Israeli
company ("Anfield"), completed their acquisitions through one brokerage firm
over the Tel Aviv Stock Exchange (the "TASE"). The reason for using one
brokerage firm was to avoid bidding against each other and to facilitate the
administration of the transactions.
Each of the Reporting Persons will, from time to time, review or
reconsider its position with respect to the Issuer and may formulate plans or
proposals with respect to any of such matters. Without limiting the foregoing,
each of the Reporting Persons may in the future seek to acquire additional
Ordinary Shares and ADS's in market transactions on the TASE or the New York
Stock Exchange and/or in privately negotiated transactions. The decision of
whether to acquire such additional Ordinary Shares or ADS's and the timing of
such acquisitions, if any, will depend, among other things, on the prevailing
prices for such securities, the availability of other investment opportunities
and the particular Reporting Person's continuing assessment of the desirability
of increasing its position in the Issuer. Furthermore, each Reporting Person
reserves the right to sell or otherwise dispose of Ordinary Shares and ADS's in
market transactions or negotiated private transactions at any time and from time
to time.
Item 5. Interest in Securities of the Issuer.
(a) Section (a) of Item 5 of the Original Schedule 13D is amended and
restated in its entirety as follows:
All percentage calculations in this Amendment No. 18 are based on
16,131,986 Ordinary Shares represented in writing to be outstanding by an
officer of the Issuer on July 24, 2005, which amount excludes 15,799 Ordinary
Shares held by the Issuer and/or a subsidiary that do not have voting rights.
CBT Holdings, Claridge and CBT
CBT Holdings directly owns 57,576 Ordinary Shares, representing 0.4% of
the issued and outstanding Ordinary Shares. Claridge directly owns 2,375,835
Ordinary Shares, representing 14.7% of the issued and outstanding Ordinary
Shares. CBT, as a result of its ownership of CBT Holdings and Claridge,
indirectly beneficially owns 2,433,411 Ordinary Shares, representing 15.1% of
the issued and outstanding Ordinary Shares.
By virtue of CBT Holdings acting together with CRBFT and Anfield in
acquiring Ordinary Shares, as described above in Section 4, CBT may be deemed to
be a member of a "group" under Section 13(d)(3) of the Exchange Act and Rule
13d-5(b)(1) thereunder (a "Section
CUSIP No.: 500 507 108 Schedule 13D Page 10 of 16 Pages
13(d) group"). As a result, each of CBT Holdings and CRBFT may be deemed to have
shared beneficial ownership of the 234,604 shares acquired by CBT Holdings,
CRBFT and Anfield, as well as (i) the 2,271,167 Ordinary Shares indirectly
beneficially owned by CRBFT through its ownership of Esarbee and (ii) 547,902
Ordinary Shares owned by Anfield in addition to the Ordinary Shares acquired on
and after July 11, 2005, the date of the first acquisition reported in this
Amendment No. 18. In the case of CBT Holdings and CBT, respectively, CBT
Holdings' status as a deemed member of a Section 13(d) group results in shared
beneficial ownership of 3,053,673 (or 18.9% of the issued and outstanding)
Ordinary Shares and 5,429,508 (or 33.7% of such) Ordinary Shares. CBT Holdings
does not have any post-acquisition plans or agreements with respect to the
Ordinary Shares being reported under this Amendment No. 18, nor any plans or
agreements with respect to the Ordinary Shares that it may acquire in the
future. Accordingly, each of CBT Holdings and CBT disclaims beneficial ownership
of the 2,996,097 Ordinary Shares of which it may be deemed to have shared
beneficial ownership as a member of any such Section 13(d) group.
Esarbee and CRBFT
Esarbee directly owns 2,271,167 Ordinary Shares, representing 14.1% of the
issued and outstanding Ordinary Shares. CRBFT directly owns 113,236 Ordinary
Shares and may be deemed to have beneficial ownership of the 2,271,167 Ordinary
Shares owned by Esarbee, for a total of 2,384,403 Ordinary Shares, which
represents 14.8% of the issued and outstanding Ordinary Shares.
As described in the second paragraph under the heading "CBT Holdings,
Claridge and CBT" above, by virtue of the purchases of Ordinary Shares by CBT
Holdings, CRBFT and Anfield being reported in this Amendment No. 18, CRBFT may
be deemed to be a member of a Section 13(d) group and to have shared beneficial
ownership of the 234,604 Ordinary Shares acquired by CBT Holdings, CRBFT and
Anfield (including the 113,236 Ordinary Shares acquired directly by CRBFT), plus
the 547,902 Ordinary Shares owned by Anfield prior to July 11, 2005, for a total
shared beneficial ownership of 3,053,673 (or 18.9% of the issued and
outstanding) Ordinary Shares. CRBFT does not have any post-acquisition plans or
agreements with respect to the Ordinary Shares being reported under this
Amendment No. 18, nor any plans or agreements with respect to the Ordinary
Shares that it may acquire in the future. Accordingly, CRBFT disclaims
beneficial ownership of the 669,270 Ordinary Shares of which it may be deemed to
have shared beneficial ownership as a member of any such Section 13(d) group.
(b) Section (b) of Item 5 of the Original Schedule 13D is hereby amended
and restated in its entirety as follows:
CBT shares voting rights and the right to dispose of its 2,433,411
indirectly beneficially owned Ordinary Shares with the respective direct owners
of such Ordinary Shares: as to 2,375,835 Ordinary Shares, these rights are
shared with Claridge, and as to 57,576 Ordinary Shares, these rights are shared
with CBT Holdings.
CRBFT and Esarbee share voting rights and the right to dispose of the
2,271,167 Ordinary Shares directly owned by Esarbee. CRBFT has sole voting
rights and the sole right to dispose of its 113,236 directly owned Ordinary
Shares.
CUSIP No.: 500 507 108 Schedule 13D Page 11 of 16 Pages
(c) Except as set forth below, during the last sixty days there have been
no transactions in the Ordinary Shares effected by the Reporting Persons, nor,
to the best of their knowledge, any of their respective Schedule I Persons:
--------------------------------------------------------------------------------
No. of Price (US$) per
Acquiring Entity Date Ordinary Shares Ordinary Share
--------------------------------------------------------------------------------
CRBFT 11-Jul-05 2,749 54.285902
--------------------------------------------------------------------------------
CBT Holdings 11-Jul-05 2,749 54.285902
--------------------------------------------------------------------------------
CRBFT 12-Jul-05 10,530 56.691313
--------------------------------------------------------------------------------
CBT Holdings 12-Jul-05 10,530 56.691313
--------------------------------------------------------------------------------
CRBFT 13-Jul-05 3,510 56.759066
--------------------------------------------------------------------------------
CBT Holdings 13-Jul-05 3,510 56.759066
--------------------------------------------------------------------------------
CRBFT 14-Jul-05 11,099 57.665333
--------------------------------------------------------------------------------
CBT Holdings 14-Jul-05 11,099 57.665333
--------------------------------------------------------------------------------
CRBFT 17-Jul-05 7,800 57.043186
--------------------------------------------------------------------------------
CBT Holdings 17-Jul-05 7,800 57.043186
--------------------------------------------------------------------------------
CRBFT 18-Jul-05 3,393 57.234926
--------------------------------------------------------------------------------
CBT Holdings 18-Jul-05 3,393 57.234926
--------------------------------------------------------------------------------
CRBFT 19-Jul-05 456 57.170966
--------------------------------------------------------------------------------
CBT Holdings 19-Jul-05 456 57.170966
--------------------------------------------------------------------------------
CRBFT 20-Jul-05 6,025 58.140821
--------------------------------------------------------------------------------
CBT Holdings 20-Jul-05 6,025 58.140821
--------------------------------------------------------------------------------
CRBFT 21-Jul-05 9,750 58.523077
--------------------------------------------------------------------------------
CBT Holdings 21-Jul-05 9,750 58.523077
--------------------------------------------------------------------------------
CRBFT 24-Jul-05 1,094 58.622222
--------------------------------------------------------------------------------
CBT Holdings 24-Jul-05 1,094 58.622222
--------------------------------------------------------------------------------
CRBFT 25-Jul-05 16,640 58.952019
--------------------------------------------------------------------------------
CRBFT 25-Jul-05 1,170 58.706687
--------------------------------------------------------------------------------
CBT Holdings 25-Jul-05 1,170 58.706687
--------------------------------------------------------------------------------
CRBFT 26-Jul-05 39,020 58.871367
--------------------------------------------------------------------------------
All of such acquisitions were effected through the same brokerage firm on the
TASE.
Item 7. Material to be Filed as Exhibits.
Exhibit 99.1. Joint Filing Agreement.
* * *
CUSIP No.: 500 507 108 Schedule 13D Page 12 of 16 Pages
SIGNATURE
After reasonable inquiry and to the best of the knowledge and belief of
the undersigned, the undersigned hereby certifies that the information contained
in this statement is true, complete and correct.
Dated: July 27, 2005
CBT HOLDINGS LLC CLARIDGE ISRAEL LLC
By: /s/ Bruce Judelson By: /s/ Bruce Judelson
---------------------------------- --------------------------------
Name: Bruce Judelson Name: Bruce Judelson
Title: Manager Title: Manager
ESARBEE INVESTMENTS LIMITED CHARLES ROSNER BRONFMAN FAMILY TRUST
By: /s/ Oded Tal By: /s/ Oded Tal
---------------------------------- --------------------------------
Name: Oded Tal Name: Oded Tal
Title: Vice President, Investments Title: Authorized Representative
By: /s/ Glenn Hamilton-Browne By: /s/ Glenn Hamilton-Browne
---------------------------------- --------------------------------
Name: Glenn Hamilton-Browne Name: Glenn Hamilton-Browne
Title: Controller Title: Authorized Representative
THE CHARLES BRONFMAN TRUST
By: /s/ Jay H. Rubinstein
--------------------------------
Name: Jay H. Rubinstein
Title: Trustee
CUSIP No.: 500 507 108 Schedule 13D Page 13 of 16 Pages
SCHEDULE I
TO SCHEDULE 13D
1) Schedule I to the Original Schedule 13D is hereby amended by adding at the
end thereof the following:
Information with Respect to Trustees and Beneficiaries of The Charles Rosner
Bronfman Family Trust.
The following sets forth as to the Trustees and beneficiaries of The Charles
Rosner Bronfman Family Trust: his or her name; his or her business address; and
his or her present principal occupation or employment and the name, principal
business and address of any corporation or other organization in which such
employment is conducted. Unless otherwise specified, the principal employer of
each such individual is Claridge, Inc., the business address of which is 1170
Peel Street, Montreal, Canada H3B 4P2, and each such individual identified below
is a citizen of Canada.
Trustees of The Charles Rosner Bronfman Family Trust
Stephen R. Bronfman
Robert S. Vineberg c/o Davies Ward Phillips & Vineberg LLP Private Investor
1501 McGill College Avenue Attorney
Montreal, Quebec, Canada H3A 3N9
Ellen Bronfman Hauptman c/o Andell Holdings, LLC Private Investor
10877 Wilshire Blvd.
Suite 2200
Los Angeles, CA 90024
Arnold M. Ludwick Vice-Chairman, Claridge, Inc.
Beneficiaries
Stephen R. Bronfman and charitable organizations
CUSIP No.: 500 507 108 Schedule 13D Page 14 of 16 Pages
SCHEDULE I
TO SCHEDULE 13D
(continued)
2) Schedule I to the Original Schedule 13D is hereby amended by replacing the
information therein with respect to Esarbee with the following:
Information with respect to the Shareholder, Trustees of the Shareholder,
Executive Officers and Directors of Esarbee Investments Limited. Information in
the Original Schedule 13D concerning Esarbee is replaced in its entirety with
the following:
The following sets forth as to each of the shareholder, trustees of the
shareholder, executive officers and directors of Esarbee Investments Limited:
his or her name; his or her business address; and his or her present principal
occupation or employment and the name, principal business and address of any
corporation or other organization in which such employment is conducted. Unless
otherwise specified, the principal employer of each such individual is Claridge,
Inc., the business address of which is 1170 Peel Street, Montreal, Canada H3B
4P2, and each such individual identified below is a citizen of Canada.
Shareholder
The Charles Rosner Bronfman Family Trust
Trustees of The Charles Rosner Bronfman Family Trust
Stephen R. Bronfman
Robert S. Vineberg
Ellen Bronfman Hauptman
Arnold M. Ludwick
Executive Officers
Stephen R. Bronfman Private Investor Chairman
Robert Fetherstonhaugh Claridge, Inc. President
Richard P. Doyle Claridge, Inc. Vice President, Corporate
Planning
Oded Tal (Israeli citizen) Claridge, Inc. Vice President, Investments
Zeno Santache Claridge, Inc. Chief Financial Officer
Christine Kofler Claridge, Inc. Secretary
Glenn Hamilton-Browne Claridge, Inc. Controller
Directors
Stephen R. Bronfman
Zeno Santache
Richard P. Doyle
Robert Fetherstonhaugh
CUSIP No.: 500 507 108 Schedule 13D Page 15 of 16 Pages
SCHEDULE I
TO SCHEDULE 13D
(continued)
3) Schedule I to the Original Schedule 13D is hereby amended by adding at the
end thereof the following after the new information for CRBFT:
Information with respect to CBT Holdings LLC.
The following sets forth as to the Managers and Member (and its trustees) of CBT
Holdings LLC: his or its name; his or its business address; and his or its
present principal occupation or employment and the name, principal business and
address of any corporation or other organization in which such employment is
conducted. Each such individual or entity identified below is a citizen of the
United States.
Member
The Charles Bronfman Trust
Trustees of The Charles Bronfman Trust
Wilmington Trust Company 1100 Market Street Trust Services
Wilmington, DE 19890-0001
Jay Rubinstein c/o Withers Bergman LLP Principal, Withers Bergman LLP
157 Church Street (law firm)
New Haven, CT 06510
Managers
Bruce Judelson c/o Withers Bergman LLP Principal, Withers Bergman LLP
157 Church Street (law firm)
New Haven, CT 06510
Scott Richland c/o Andell Holdings, LLC President, Andell Holdings, LLC
10877 Wilshire Blvd (Private investment holding
Suite 2200 company)
Los Angeles, California 90024